181 related articles for article (PubMed ID: 16780552)
1. A novel endoscopic approach to brachytherapy in the management of Hilar cholangiocarcinoma.
Simmons DT; Baron TH; Petersen BT; Gostout CJ; Haddock MG; Gores GJ; Yeakel PD; Topazian MD; Levy MJ
Am J Gastroenterol; 2006 Aug; 101(8):1792-6. PubMed ID: 16780552
[TBL] [Abstract][Full Text] [Related]
2. Endoscopically inserted nasobiliary catheters for high dose-rate brachytherapy as part of neoadjuvant therapy for perihilar cholangiocarcinoma.
Mukewar S; Gupta A; Baron TH; Gores G; Furutani K; Haddock MG; Hallemeier CL
Endoscopy; 2015 Oct; 47(10):878-83. PubMed ID: 25961442
[TBL] [Abstract][Full Text] [Related]
3. [Percutaneous treatment of hilar cholangiocarcinoma completed by high-dose rate brachytherapy. Experience in the first 5 cases].
Righi D; Maass J; Zanon E; Tettoni S; Orecchia R; Lazzari R; Ragona R; Gandini G
Radiol Med; 1994; 88(1-2):79-85. PubMed ID: 7520594
[TBL] [Abstract][Full Text] [Related]
4. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
Isayama H; Tsujino T; Nakai Y; Sasaki T; Nakagawa K; Yamashita H; Aoki T; Koike K
World J Gastroenterol; 2012 May; 18(19):2364-70. PubMed ID: 22654427
[TBL] [Abstract][Full Text] [Related]
5. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study.
Válek V; Kysela P; Kala Z; Kiss I; Tomásek J; Petera J
Eur J Radiol; 2007 May; 62(2):175-9. PubMed ID: 17344008
[TBL] [Abstract][Full Text] [Related]
6. Malignant biliary duct obstruction: long-term experience with Gianturco stents and combined-modality radiation therapy.
Eschelman DJ; Shapiro MJ; Bonn J; Sullivan KL; Alden ME; Hovsepian DM; Gardiner GA
Radiology; 1996 Sep; 200(3):717-24. PubMed ID: 8756921
[TBL] [Abstract][Full Text] [Related]
7. Unresectable perihilar cholangiocarcinoma: multimodal palliative treatment.
Mosconi C; Renzulli M; Giampalma E; Galuppi A; Balacchi C; Brandi G; Ercolani G; Bianchi G; Golfieri R
Anticancer Res; 2013 Jun; 33(6):2747-53. PubMed ID: 23749936
[TBL] [Abstract][Full Text] [Related]
8. [Unresectable hilar cholangiocarcinoma: combined percutaneous and radiotherapic treatment].
Golfieri R; Giampalma E; Muzzi C; Maffei M; Amore B; Grazia C; Frezza G; Galuppi A; Gavelli G
Radiol Med; 2001 Jun; 101(6):495-502. PubMed ID: 11479448
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of slimmer and open-cell-design stents for endoscopic bilateral stenting and endoscopic revision in patients with hilar cholangiocarcinoma (with video).
Kim JY; Kang DH; Kim HW; Choi CW; Kim ID; Hwang JH; Kim DU; Eum JS; Bae YM
Gastrointest Endosc; 2009 Dec; 70(6):1109-15. PubMed ID: 19647244
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic irradiation and parallel arrangement of Wallstents for hilar cholangiocarcinoma.
Kubota Y; Takaoka M; Kin H; Ogura M; Yamamoto S; Tsuji K; Yanagitani K; Inoue K
Hepatogastroenterology; 1998; 45(20):415-9. PubMed ID: 9638416
[TBL] [Abstract][Full Text] [Related]
11. Unresectable hilar cholangiocarcinoma: multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy.
Golfieri R; Giampalma E; Renzulli M; Galuppi A; Vicenzi L; Galaverni MC; Cappelli A
In Vivo; 2006; 20(6A):757-60. PubMed ID: 17203762
[TBL] [Abstract][Full Text] [Related]
12. A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma.
Bowling TE; Galbraith SM; Hatfield AR; Solano J; Spittle MF
Gut; 1996 Dec; 39(6):852-5. PubMed ID: 9038668
[TBL] [Abstract][Full Text] [Related]
13. [Palliative locoregional therapy for hilar cholangiocarcinoma: photodynamic therapy and brachytherapy].
Dumoulin FL; Horst E; Sauerbruch T; Gerhardt T
Zentralbl Chir; 2007 Aug; 132(4):336-41. PubMed ID: 17724637
[TBL] [Abstract][Full Text] [Related]
14. Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy.
Kuvshinoff BW; Armstrong JG; Fong Y; Schupak K; Getradjman G; Heffernan N; Blumgart LH
Br J Surg; 1995 Nov; 82(11):1522-5. PubMed ID: 8535808
[TBL] [Abstract][Full Text] [Related]
15. Intraluminal brachytherapy in bile duct carcinomas.
Leung J; Guiney M; Das R
Aust N Z J Surg; 1996 Feb; 66(2):74-7. PubMed ID: 8602818
[TBL] [Abstract][Full Text] [Related]
16. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
[TBL] [Abstract][Full Text] [Related]
17. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct.
Kocak Z; Ozkan H; Adli M; Garipagaoglu M; Kurtman C; Cakmak A
Radiat Med; 2005 May; 23(3):200-7. PubMed ID: 15940068
[TBL] [Abstract][Full Text] [Related]
18. A quality assurance device for measuring afterloader performance and transit dose for nasobiliary high-dose-rate brachytherapy.
Deufel CL; Mullins JP; Zakhary MJ
Brachytherapy; 2018; 17(4):726-731. PubMed ID: 29779953
[TBL] [Abstract][Full Text] [Related]
19. Intraluminal low-dose-rate 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma.
Takamura A; Saito H; Kamada T; Hiramatsu K; Takeuchi S; Hasegawa M; Miyamoto N
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1357-65. PubMed ID: 14630274
[TBL] [Abstract][Full Text] [Related]
20. Y-shaped endoscopic bilateral metal stent placement for malignant hilar biliary obstruction: prospective long-term study.
Hwang JC; Kim JH; Lim SG; Kim SS; Yoo BM; Cho SW
Scand J Gastroenterol; 2011 Mar; 46(3):326-32. PubMed ID: 21082874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
